Chemopreventive Agent Development

Designs, develops, implements, and monitors research on interventions that may block, reverse, or delay the early stages of cancer. Investigates nutrients, micronutrients, natural products, pharmacologic agents, biomolecules, and vaccines from preclinical to early-phase I clinical studies. Helps investigators to bridge the gaps between biology and identifying potential targets, and between discovery of targets and agents and clinical testing in people.

Major Programs

Staff List

Grid View

Name, Email, Phone	Room	Group(s)/Office
Asefa, Wosene wosene.asefa@nih.gov 240-276-6422	5E504	Program Support Assistant \| Chemopreventive Agent Development
Biswas, Kajal, Ph.D. kajal.biswas2@nih.gov 240-276-5614	5E540	Program Officer \| Chemopreventive Agent Development
Cholewa, Brian, Ph.D. brian.cholewa@nih.gov 240-276-7545	5E446	Deputy Chief \| Chemopreventive Agent Development
Clifford, John, Ph.D. john.clifford@nih.gov 202-235-4482	5E430	Program Officer \| Chemopreventive Agent Development
Gunasekharan, Vignesh, Ph.D. vignesh.gunasekharan@nih.gov 240-276-5814	5E438	Program Officer \| Chemopreventive Agent Development
Mohammed, Altaf, Ph.D. altaf.mohammed@nih.gov 240-276-6082	5E542	Deputy Chief \| Chemopreventive Agent Development
Nalli, Ancy, Ph.D., M.S. ancy.nalli@nih.gov 202-276-5265	5E536	Program Officer \| Chemopreventive Agent Development
Sei, Shizuko, M.D. shizuko.sei@nih.gov 240-276-5005	5E452	Co-Chief \| Chemopreventive Agent Development
Shoemaker, Robert, Ph.D. robert.shoemaker@nih.gov 240-276-7077	5E454	Co-Chief \| Chemopreventive Agent Development Acting Chief \| Nutritional Science
Vlad, Anda, M.D., Ph.D. anda.vlad@nih.gov 240-276-6422	5E538	Program Officer \| Chemopreventive Agent Development

Grants

PI Name Sort descending	PI Organization	Title	Grant Number	Program Official
Iyer, Prasad G.	Mayo Clinic Arizona United States	Minimally Invasive Molecular Approaches for the Detection of Barrett’s Esophagus and Esophageal Adenocarcinoma	2R01CA241164-07	Matthew Young, Ph.D.
Jacob, Jennifer B	Henry Ford Health + Michigan State University Health Sciences United States	Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice	5R01CA278818-03
James, Aimee S	Washington University United States	Administrative Supplement to Building equity in cancer screening through research: The Siteman Catchment CSRN Hub	3UG1CA286946-02S1	Elyse LeeVan, M.D., M.P.H.
Jang, Mi-Hyeon	Rutgers Biomedical And Health Sciences United States	Identification of novel biomarkers and therapeutic strategies in chemobrain.	5R01CA293210-02	John Clifford, Ph.D.
Jaslowski, Anthony J	St. Vincent Hospital United States	Cancer Research of Wisconsin and Northern Michigan (CROWN) Consortium	3UG1CA239769-06S1	Vanessa A. White, M.P.H.
Ji, Hanlee P	Stanford University United States	Single-molecule nanopore-based identification of methylome signatures in cfDNA for early colorectal cancer detection	5U01CA282212-02	Claire Zhu, Ph.D.
Ji, Hanlee P	Stanford University United States	Precision Interception of Gastric Cancer Precursors Through Molecular and Cellular Risk Stratification	5P01CA265772-03	Asad Umar, D.V.M., Ph.D.
Jiang, Qing	Purdue University United States	Anti-cancer effects of tocotrienols and a carboxychromanol in an innovative colon cancer model	5R03CA283236-02	Amit Kumar, Ph.D.
Jiang, Feng	Biotarget Dx Llc United States	Plasma microRNA biomarkers for lung cancer diagnosis	7UH3CA251139-05	Guillermo Marquez, Ph.D.
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Adaptation and Preliminary Evaluation of Energize-MBC: Cognitive Behavioral Therapy for Fatigue among Women with Metastatic Breast Cancer	5R34CA289918-02	Brennan Streck, Ph.D., RN, M.P.H.
Jim, Heather S.L.	H. Lee Moffitt Cancer Ctr & Res Inst United States	Randomized Placebo Controlled Trial of Bupropion for Cancer Related Fatigue	5R01CA214647-05	Brandy Heckman-Stoddard, Ph.D., M.P.H.
Jobin, Christian	University Of Florida United States	Interaction between dietary taurine and microbiota sulfur metabolism in the development of colorectal cancer	1R01CA296643-01	Young Kim, Ph.D.
John, Esther M.	Stanford University United States	Stress, inflammation, and health-related quality of life of long-term breast cancer survivors	1R21CA290430-01	Brennan Streck, Ph.D., RN, M.P.H.
Johnson, Jeremy James	University Of Illinois At Chicago United States	Defining the role of isoprenylated xanthones from the mangosteen for enhancing degradation of full length and variant forms of androgen receptor in prostate cancer	5R37CA227101-07	Amit Kumar, Ph.D.
Johnson, Constance Margaret	University Of Texas Hlth Sci Ctr Houston United States	Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy	3R01CA245054-05S1	Rachel Altshuler, Ph.D.

Chemopreventive Agent Development

On This Page

Major Programs

Staff List

Grants